$2.67T
Total marketcap
$48.56B
Total volume
BTC 49.91%     ETH 17.07%
Dominance

Hologic, Inc. 0J5Q.L Stock

72.75 USD {{ price }} -1.417217% {{change_pct}}%
Exchange
LSE
Market Cap
194.74M USD
LOW - HIGH [24H]
72.65 - 72.91 USD
VOLUME [24H]
331 USD
{{ volume }}
P/E Ratio
0.12
Earnings per share
6.06 USD

Hologic, Inc. Price Chart

Hologic, Inc. 0J5Q.L Financial and Trading Overview

Hologic, Inc. stock price 72.75 USD
Previous Close 79.21 USD
Open 0 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0 - 0 USD
52 Week Range 0 - 86.55 USD
Volume 1.95K USD
Avg. Volume 1.47K USD
Market Cap 214.59M USD
Beta (5Y Monthly) 1.012676
PE Ratio (TTM) 0.13240297
EPS (TTM) 6.06 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0J5Q.L Valuation Measures

Enterprise Value 19.73B USD
Trailing P/E 0.13240297
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.05289884
Price/Book (mrq) 3.7222583
Enterprise Value/Revenue 4.864
Enterprise Value/EBITDA 14.896

Trading Information

Hologic, Inc. Stock Price History

Beta (5Y Monthly) 1.012676
52-Week Change 17.73%
S&P500 52-Week Change 20.43%
52 Week High 86.55 USD
52 Week Low 0 USD
50-Day Moving Average 81.65 USD
200-Day Moving Average 76.07 USD

0J5Q.L Share Statistics

Avg. Volume (3 month) 1.47K USD
Avg. Daily Volume (10-Days) 523 USD
Shares Outstanding 289.21M
Float 244.09M
Short Ratio N/A
% Held by Insiders 0.73%
% Held by Institutions 100.05%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 24, 2022
Most Recent Quarter (mrq) April 1, 2023
Next Fiscal Year End September 24, 2023

Profitability

Profit Margin 18.56%
Operating Margin (ttm) 23.21%
Gross Margin 62.65%
EBITDA Margin 32.65%

Management Effectiveness

Return on Assets (ttm) 6.20%
Return on Equity (ttm) 14.91%

Income Statement

Revenue (ttm) 4.06B USD
Revenue Per Share (ttm) 16.29 USD
Quarterly Revenue Growth (yoy) -28.49%
Gross Profit (ttm) 3.31B USD
EBITDA 1.32B USD
Net Income Avi to Common (ttm) 753M USD
Diluted EPS (ttm) 6.055
Quarterly Earnings Growth (yoy) -52.10%

Balance Sheet

Total Cash (mrq) 2.61B USD
Total Cash Per Share (mrq) 10.6 USD
Total Debt (mrq) 2.84B USD
Total Debt/Equity (mrq) 53.66 USD
Current Ratio (mrq) 4.41
Book Value Per Share (mrq) 21.538

Cash Flow Statement

Operating Cash Flow (ttm) 959M USD
Levered Free Cash Flow (ttm) 726.48M USD

Profile of Hologic, Inc.

Country United Kingdom
State MA
City Marlborough
Address 250 Campus Drive
ZIP 01752
Phone 508 263 2900
Website https://www.hologic.com
Industry
Sector(s)
Full Time Employees 6944

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Q&A For Hologic, Inc. Stock

What is a current 0J5Q.L stock price?

Hologic, Inc. 0J5Q.L stock price today per share is 72.75 USD.

How to purchase Hologic, Inc. stock?

You can buy 0J5Q.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Hologic, Inc.?

The stock symbol or ticker of Hologic, Inc. is 0J5Q.L.

How many shares does Hologic, Inc. have in circulation?

The max supply of Hologic, Inc. shares is 2.68M.

What is Hologic, Inc. Price to Earnings Ratio (PE Ratio)?

Hologic, Inc. PE Ratio is 0.12015541 now.

What was Hologic, Inc. earnings per share over the trailing 12 months (TTM)?

Hologic, Inc. EPS is 6.06 USD over the trailing 12 months.